Dimensional Fund Advisors LP Purchases 11,196 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Dimensional Fund Advisors LP boosted its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 6.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 186,700 shares of the medical instruments supplier’s stock after buying an additional 11,196 shares during the quarter. Dimensional Fund Advisors LP owned approximately 5.51% of Utah Medical Products worth $11,476,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its stake in shares of Utah Medical Products by 10.6% during the third quarter. JPMorgan Chase & Co. now owns 69,411 shares of the medical instruments supplier’s stock valued at $4,644,000 after acquiring an additional 6,645 shares during the last quarter. Sanctuary Advisors LLC raised its position in Utah Medical Products by 16.1% during the 4th quarter. Sanctuary Advisors LLC now owns 6,961 shares of the medical instruments supplier’s stock valued at $426,000 after purchasing an additional 963 shares during the last quarter. American Century Companies Inc. raised its position in Utah Medical Products by 8.6% during the 4th quarter. American Century Companies Inc. now owns 8,135 shares of the medical instruments supplier’s stock valued at $500,000 after purchasing an additional 643 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in shares of Utah Medical Products by 838.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 11,698 shares of the medical instruments supplier’s stock worth $719,000 after buying an additional 10,452 shares during the last quarter. Finally, Barclays PLC increased its stake in shares of Utah Medical Products by 214.1% during the third quarter. Barclays PLC now owns 4,574 shares of the medical instruments supplier’s stock valued at $306,000 after buying an additional 3,118 shares during the period. Hedge funds and other institutional investors own 69.60% of the company’s stock.

Utah Medical Products Stock Down 0.5 %

Shares of Utah Medical Products stock opened at $53.61 on Friday. The company has a market cap of $175.95 million, a PE ratio of 13.57 and a beta of 0.30. The business has a 50 day moving average of $54.93 and a 200 day moving average of $60.05. Utah Medical Products, Inc. has a 52 week low of $51.26 and a 52 week high of $77.33.

Utah Medical Products (NASDAQ:UTMD) last posted its earnings results on Tuesday, April 29th. The medical instruments supplier reported $0.92 EPS for the quarter. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%. The firm had revenue of $9.71 million during the quarter.

Utah Medical Products Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 3rd. Shareholders of record on Monday, June 16th will be issued a dividend of $0.305 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.28%. Utah Medical Products’s dividend payout ratio (DPR) is 32.28%.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.